The beta-glucan market is evaluated at US$370.313 million for the year 2020 growing at a CAGR of 7.16% reaching the market size of US$600.982 million by the year 2027.
Beta-glucan is a type of dietary fibre that offers several benefits on consumption, such as an improvement in cholesterol levels and also helps in the improvement of heart health. The market for beta-glucan is projected to witness healthy growth over the next five years, which is attributable to the fact that the health benefits associated with it have led to an upsurge in consumption. The growing prevalence of chronic health issues such as diabetes, cholesterol, and other diseases has further led to an increased demand for health and wellness products, which in turn is also playing a significant role in shaping the beta-glucan market growth during the next five years. The inclination of consumers toward personal health is also positively impacting the market growth of nutraceutical products, particularly in the developed regions such as North America and Europe. The rising participation by the players operating in the market in the form of acquisitions, partnerships, and increased investments in R&D for the launch of new products further shows the potential for market growth soon. As a result, manufacturers will benefit from lucrative business opportunities over the next five years.
The outbreak of the novel coronavirus disease is anticipated to positively impact the market growth to some extent. The key factor supplementing the growth during the short run is the upsurge in the consumption of a healthy diet to boost the immunity system. The increased consumption of healthy foods further acts as a catalyst for positive market growth amid the disease. Additionally, the consumption of functional foods has also increased significantly, thus, creating a positive demand for beta-glucan during the short period of six to eight months.
The beta-glucan market has been segmented based on type, source, and application. Based on type, the classification of the market has been done into soluble and insoluble. By source, the segmentation of the market has been done as cereals, mushrooms, yeast, and others. By application, the market has been segmented into food and beverages, cosmetics and personal care, pharmaceuticals, and others. The market has been divided into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific.
The growing prevalence of diseases is driving the market growth
One of the primary factors that are playing a major role in boosting the beta-glucan market growth is the constantly growing prevalence of chronic diseases such as CVDs, diabetes, and obesity in many parts of the world. As per the latest reports from the U.S Department of Health and Human Services, one out of ten Americans has diabetes, and one out of three American adults has prediabetes. Similarly, as per the statistics from the World Health Organization, approximately 17.9 million people die each year due to cardiovascular diseases, which account for almost 31% of the total deaths worldwide. This, in turn, has further propelled the consumption of functional foods and beverages since there are growing concerns regarding personal health.
Mushrooms are expected to grow rapidly. According to the source, the cereals segment is anticipated to hold a significant share in the market, which is attributed to the fact that cereals have a positive impact on human health. However, on the other hand, mushroom-based beta-glucan is anticipated to witness significant growth during the next five years owing to its wide applications in cosmetic products.
The Asia Pacific will have a sizable share. Geographically, the Asia Pacific region is expected to hold a decent share in the market, which is primarily attributable to the fact that the presence of a vast industrial base in countries like China, India, and Japan is a major factor supporting the demand for beta-glucan.
Key Developments in the Market:
There are a significant number of companies working in the beta-glucan market. However, some have solidified their position as the leading providers in this industry. These players are involved in a plethora of investments, product launches, and R&D as a part of their growth strategies to further strengthen their position and provide better products and services to their customers worldwide, which is further expected to propel the growth of the market in the coming years. Some of these are:
In July 2020, Hibercell Inc., one of the globally known therapeutic molecule development companies, announced that it would acquire Biothera Pharmaceuticals’ Imprime PGG Program.
In July 2020, Immudyne Nutritional, a 30-year-old expert company that offers nutritional ingredients, announced the launch of a new product, PureMune, which is a science-based branded beta-glucan ingredient for immune health.
In June 2020, Biotec Pharmacon announced its rebranding to ArcticZymes Technologies ASA to enhance its brand identity and capture a greater share in the market.
In January 2020, Herbalife Nutrition announced the launch of a new product, Beta Heart, which primarily offers better cardiovascular health. The product contains oat beta-glucan, which helps in the reduction of and maintenance of blood cholesterol.
In December 2020, Danstar Ferment AG, food ingredients manufacturer and supplier, announced its acquisition of Biotec BetaGlucans AS, producer and supplier of beta-glucan-based products. The latter intends to expand its product portfolio of beta-glucans to animal and human nutrition sectors through this acquisition.
In July 2021, Israel-based Solabia-Algatech Nutrition launched its new product—BioGlena—an algae-based beta-glucan immune support product. The beta-glucan was obtained from whole algae called Euglena gracilis. According to the company, this said immune cell receptors particularly recognize E.gracilis-based beta-glucan.
In March 2022, New Beauty launched Bliss's new product, Mighty Biome, on an online shopping platform, Walmart.com. This cleansing balm features a prebiotic and postbiotic called beta-glucan and Lactococcus Ferment Lysate, respectively, along with squalene, ceramide NP, and beta carotene.
Covid-19 had a significant impact on the beta-glucan market. Amid the global pandemic, the health awareness among the people increased, thus increasing the demand for nutritional food. Consequently, the need for nutritious food and immune boosters surged. However, the mandated lockdown, rising infected cases, and social distancing measures led to partial or complete closure of production facilities and reduced staffing. This resulted in a short supply and demand chain gap, slowing the market growth. Nevertheless, increasing chronic diseases owing to sedentary lifestyles are expected to add impetus to the growth of the market in upcoming years.
Prominent/major key market players in the beta-glucan market include Kerry Group plc, DSM, and Ceapro Inc., among others. The players in the beta-glucan market are implementing various growth strategies to gain a competitive advantage over their competitors in this market. Major market players in the market have been covered along with their relative competitive strategies. The report also mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered, along with the recent deals and investments of these important players in the beta-glucan market.
Frequently Asked Questions (FAQs)
Q1. What will be the beta-glucan market size by 2027?
A1. The beta-glucan market is projected to reach a total market size of US$600.982 million in 2027.
Q2. What are the growth prospects for the beta-glucan market?
A2. The global beta-glucan market is projected to grow at a CAGR of 7.16% during the forecast period.
Q3. What is the size of the global beta-glucan market?
A3. Beta-Glucan Market was valued at US$370.313 million in 2020.
Q4. What factors are anticipated to drive the beta-glucan market growth?
A4. One of the primary factors driving the beta-glucan market growth is the constantly growing prevalence of chronic diseases such as CVDs, diabetes, and obesity in many parts of the world.
Q5. Which region holds the largest market share in the beta-glucan market?
A5. Geographically, the Asia Pacific region is expected to hold a decent share in the beta-glucan market owing to the fact that the presence of a vast industrial base in countries like China, India, and Japan.
Kerry Group plc
AngelYeast Co., Ltd.
Garuda International, Inc.
Lantmännen Oats Ab
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.